This is filed for an increase in mean pressure gradient to 10mm hg, one day post procedure.It was reported that this was a mitraclip procedure to treat tricuspid regurgitation (tr) with a grade of 4 with thickened leaflets and a posterior prolapse.Two mitraclips were implanted, successfully reducing tr to 1 and a gradient of 4-5 mmhg.There was no clinically significant delay in the procedure.One day post procedure, the gradient had increased to 10 mmhg.The patient had no symptoms and was discharged as planned.No additional information was provided.
|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.It was also reported that the procedure was used to treat tricuspid regurgitation.It should be noted that the intended use section of the mitraclip system, instruction for use states: ¿the mitraclip system is intended for reconstruction of the insufficient mitral valve through tissue approximation¿.Based on the information reviewed, the reported patient selection (off label use) was associated with the use of the mitraclip device on the tricuspid valve, which is considered an off-label use of the device.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.Mfr site - contact office first and last name.
|